← The Wire
CUENasdaq
Cue Biopharma, Inc.
Pharmaceutical Preparations · DE · CIK 1645460
Developing injectable therapeutics to selectively engage and modulate disease-specific T cells for autoimmune and inflammatory diseases
red 8-K · 90d
$103M
Market cap
$30.43
Last close
+19.9%
1D
-1.0%
5D
164K
Volume
Price · last 39 sessions+1.9%
May 4L $20.03 · H $35.73Jun 29
176
Total filings
Jun 3, 2026
Last filing
12/31
Fiscal year end
424B5424B5Dec 19, 2025424B5424B5Dec 18, 2025424B5424B5Apr 15, 2025424B5424B5Apr 14, 2025424B5424B5Sep 27, 2024424B5424B5Sep 26, 2024424B5424B5Oct 1, 2021424B5424B5Oct 1, 2021424B5424B5Jun 22, 2020424B5424B5Mar 27, 2020424B5424B5Nov 25, 2019424B5424B5Jun 5, 2019
Insider Activity
In the 90 days to Dec 30, 2025: 1 insider bought $100K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 86,947 | $0.32 | $28K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 78,116 | $0.31 | $24K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 77,417 | $0.30 | $23K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 77,148 | $0.30 | $23K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 4,229 | $0.31 | $1K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance